glp-1 news today september 29 2025 receptor agonists are increasingly used to treat type 2 diabetes and obesity, and trials have shown reductions in cardiovascular risk and slowing of kidney failure. Adverse events are mostly gastrointestinal. Read GLP-1 RA Adherence Shows Drop-Off

The majority of patients observe a discernible improvement in the brightness, texture, and tone of their skin

10.1016/j.jep.2015.02.026 Summary Keywords therapeutic polysaccharides of natural origin, type 2 diabetes mellitus, structural characterization, complications of type 2 diabetes mellitus, mechanism Citation Liu Z, Wang H, Gong X, Jiang X, Yang K, Jiang L, Wang Z and Tong Q (2025) Recent advances in natural polysaccharides for type 2 diabetes management: sources, structural characteristics, and mechanistic insights

WHAT ABOUT LONG TERM UP-KEEP

Conclusion: When and how to safely switch GLP-1 medications GLP-1 medications have complex dosing schedules

Mood Regulation: Keeps your spirits up and mental health in check